English

Tekbiotech-Yeast Display Service,Phage display technology

Services

Inquiry and ordering

  • Name*

  • Phone*

  • Email*

  • Product*

  • Content*

Small Molecule Nucleic Acid Aptamer Screening Service

TekBiotech is committed to providing customers with high-affinity and high-specificity nucleic acid aptamer screening technology services, and providing strong support for customers' subsequent aptamer function verification (including affinity verification, competitive ELISA verification, in vitro targeted cell functional verification (for example: nucleic acid aptamer in vitro recognition and inhibition function verification, in vitro flow blocking function, etc.), in vivo functional verification (for example: aptamer in vivo targeted inhibition function verification, signal pathway blocking function verification, etc.)) and the development of targeted specific molecular drugs and other downstream R&D work. TekBiotech has many years of project experience and experience in nucleic acid aptamer screening (SELEX technology). After years of project accumulation, we found that conventional small molecules can be screened with conventional nucleic acid aptamer libraries after specific chemical modification, but many small molecules cannot be modified, and the cost of obtaining small molecule compounds is very high. Therefore, scientists at TechBio have constructed a screening system based on nucleic acid aptamer conformational changes, with the help of which we can provide customers with high-quality small molecule nucleic acid aptamer screening services.


█ Small Molecule Nucleic Acid Aptamer Screening Service (SELEX Screening Technology Service)

 

Nucleic acid aptamer screening refers to the principle of systematic evolution of ligands by exponential enrichment (SELEX), which is based on the principle of exponential enrichment. Through incubation, washing and amplification of the target molecule and the nucleic acid aptamer library, the target oligonucleotide fragment (DNA fragment or RNA fragment) is obtained from the nucleic acid aptamer library.

The nucleic acid aptamer library established by TekBiotech has a capacity of 10^14, which is theoretically sufficient to meet the requirements of nucleic acid aptamer screening for any target point. The affinity of the candidate aptamer sequence can reach the nM-pM level.

For conventional chemical small molecules, the screening of small molecule compound modification is applicable. The screening steps are shown in Figure 1:


Small Molecule Nucleic Acid Aptamer Screening Service-tekbiotech1.png 

Figure1 SELEX nucleic acid aptamer screening service process based on small molecule modification


For unconventional chemical small molecules, such as metal ions, toxin small molecules, etc., TekBiotech uses conformational changes and photoelectric reporting systems. We redesigned the nucleic acid aptamer library from the original 40nt length to a 28nt length saturation mutation library and redesigned the homologous arms at both ends of the saturation mutation region. Finally, the library was immobilized for subsequent small molecule screening. As shown in Figure 2, the screening steps of unconventional small molecules are as follows:

 Small Molecule Nucleic Acid Aptamer Screening Service-tekbiotech2.png

Figure 2 Screening service process based on SELEX nucleic acid aptamer conformational changes

 

The antigen screening (including but not limited to proteins, peptides, amino acids, small molecules, etc.) that can be provided are diverse, and the methods of aptamer screening are also diverse (for example: magnetic beads-SELEX, cell-SELEX, capture-SELEX, etc.). The commonly used screening method is magnetic beads screening. For special samples, the screening method will be different. For example, drug small molecules need to screen aptamers, and small molecule modification technology is often required. Scientists at TekBiotech will evaluate according to the customer's project needs and design the best plan for antigen modification and aptamer screening.

Relying on its own nucleic acid aptamer screening technology platform, TekBiotech will conduct detailed evaluations based on different customer requirements. The core of the aptamer screening process lies in the mutual cooperation of SELEX technology and screening scheme. The complete system is conducive to selecting nucleic acid molecules with high affinity binding to specific targets from a huge nucleic acid sequence library through repeated selection and amplification steps. Customers only need to provide basic information of the target molecule, and our scientists will make reasonable scheme design based on the specific target molecule information to deliver high-quality nucleic acid aptamers to customers. In addition, TekBiotech can also provide a variety of downstream verification experiments such as affinity verification of nucleic acid aptamers (including BLI affinity verification and SPR affinity verification), competitive ELISA verification, flow blocking verification, etc.


█ Small Molecule Nucleic Acid Aptamer Screening Service Content and Cycle


Steps

Service Content

Cycle

Step1:Nucleic acid aptamer screening

1) The customer provides screening target information, and TekBiotech conducts project evaluation and modification (conventional modification: biotin modification);

2) Library enrichment and screening: 6-10 rounds of screening, SA magnetic bead negative screening; NGS sequencing;

3) Delivery: 10-50 aptamer sequences, including frequency of occurrence; experimental report;

8-12 Weeks

Step2:Aptamer synthesis and 

affinity determination

1) Synthesize biotin-labeled aptamers (design and synthesis according to specific circumstances);

2) Rapid affinity determination of aptamers and targets (affinity sorting);

3) Delivery: synthesis report, affinity determination experimental report, original data;

3-4 Weeks

  

█ Advantages of Small Molecule Nucleic Acid Aptamer Screening Service

 

Small Molecule Nucleic Acid Aptamer Screening Service-tekbiotech3.pngSmall Molecule Nucleic Acid Aptamer Screening Service-tekbiotech4.pngSmall Molecule Nucleic Acid Aptamer Screening Service-tekbiotech5.pngSmall Molecule Nucleic Acid Aptamer Screening Service-tekbiotech6.pngSmall Molecule Nucleic Acid Aptamer Screening Service-tekbiotech7.pngSmall Molecule Nucleic Acid Aptamer Screening Service-tekbiotech8.png


A variety of screening targets

are available: proteins, 

peptides, amino acids, small

molecules, etc.


Large library capacity, high

project success rate


Mature SELEX technology

platform: the affinity of

nucleic acid aptamers

obtained by screening can

reach nM- pM level


Rich supporting downstream

verification experiments:

affinity verification (including

BLI and SPR affinity 

verification), competitive 

ELISA verification, flow 

blocking verification, etc.


Experimental records are 

traceable: Chinese and English

experimental reports, original

experimental records


One-to-one personalized

solution customization to

meet the scientific 

research project needs 

of various customers


Recommended Services

RECOMMENDED SERVICES
*
*
*
*

×

Small Molecule Nucleic Acid Aptamer Screening Service Frequently Asked Questions

  • What is a small molecule nucleic aptamer?

    Aptamers, also known as nucleic acid aptamers, are an in vitro screening technique that uses systematic evolution of ligands by exponential enrichment (SELEX) to obtain structured oligonucleotide sequences. The sequences obtained by technical screening can be nucleic acid or deoxynucleic acid. These sequences can recognize them and bind to specific small molecules with strong affinity. Single-stranded oligonucleotides undergo a complex adaptive folding process, forming specific three-dimensional spatial structures using various intermolecular forces such as complementary pairing between nucleotides, hydrogen bond formation, π - π stacking effects, and electrostatic interactions. Next, these three-dimensional structures bind to the target small molecules using intermolecular interaction forces. In recent years, small molecule nucleic aptamer has shown its application potential in the detection of pollutants in the two disciplines of environmental engineering and food science. Small-molecule pollutants are the main detection objects in these two major disciplines. Pollutants include toxins, antibiotics, endocrine disruptors, pesticides, and other substances, which have a great impact on human health and food safety, so how to detect them is now a hot area of research. Due to the importance of contaminants, aptamer screening techniques for small molecule targets have now become a new field for scientists to explore.TEK Biotech can provide customers with small molecule aptamer services, facilitating the establishment of follow-up testing methods and other applications.

  • The advantages of small-molecule nucleic aptamers compared with antibodies?

    As a detection tool in the field of modern scientific research, small molecule nucleic aptamer is considered an alternative product of antibodies and can play its role in the field of detection technology, drug development, and biology. In contrast to the tedious preparation of antibodies, the preparation of aptamer abandoned the reaction and binding in the organism and chose to select the sequence of the oligonucleotide with high affinity capable of binding to the target small molecules in vitro. During the in vitro screening process, the experimenter can adjust various parameters, such as the temperature of incubation, PH, and incubation time, to improve the performance of the best-obtained aptamer. At the same time, after the target sequence is screened and identified, we can use the machine to synthesize the sequence. A high degree of automation in this process can ensure that the differences between the sequences produced in each synthesis are very small. In extreme environments such as high temperature, and strong acid and base environments, the stability of the aptamers is also stronger than the naturally produced antibodies, and they can quickly recover their natural structure, and again bind to the target small molecules. Aptamers are also able to quickly complete labeling, whether fluorescent, nanoparticles, or other functional groups, providing an ideal component choice for biosensor construction.

  • Three kinds of methods commonly used for screening aptamer, and how to solve them?

    Currently, the three main screening techniques used by scientists are target fixation-based screening technology, innovative Capture-SELEX (library fixation screening technology), and GO-SELEX (SELEX using graphene oxide). Although the method of target fixation may affect the result due to steric hindrance and other conditions, this method is simple to operate and is deeply loved by people. At the same time, the Capture-SELEX technology, which has been widely used in recent years, also needs our special attention. Given the above three technologies, We selected the key experimental conditions such as library design, positive screen target concentration setting, negative screen target selection, and concentration control, and then found the relationship between the affinity and specificity of the aptamer. By analyzing the screening process and results of more than 30 different target aptamers, some scientists found that the affinity of the aptamer can be improved if the concentration of the positive screening target is lowered, but this step is not necessary in the experimental process. Scientists have also found that the specificity of the aptamers obtained by existing technologies makes it difficult to meet some application criteria. We can adopt a negative screening technology that can help us improve the specificity of the aptamer and optimize our screening process.

  • How do small-molecule nucleic aptamers change their performance through various modifications?

    During the development of small-molecule aptamers, the researchers have discovered and used different modifying groups, including DNA / RNA bases, sugars, and phosphate components, to modify the aptamers. Notable is that the sugar and phosphate group of aptamer modification, helps aptamer improve the ability of nuclease to its degradation, the group after the modification of aptamer ability, can help small molecule aptamer better should be in drug discovery, the development of biosensor and other fields. In addition, some groups can modify the aptamer, which can help stabilize the three-dimensional spatial conformation of the active aptamer, which in turn promotes tight binding to the target small molecules. In addition, some groups can modify the aptamer, which can help stabilize the three-dimensional spatial conformation of the active aptamer, which in turn promotes tight binding to the target small molecules. In the field of small molecule aptamer recognition, the literature enhancing DNA / RNA aptamer specificity by base modification is now scarce. In published studies, researchers have used thymine to replace conventional uracil and added other modified DNA aptamers to maintain binding activity to ATP, despite a reduced affinity. This study demonstrates that the introduction of external functional groups within a reasonable range can expand the application of aptamers without significantly interfering with the aptamer core function.

  • In small molecule aptamers, traditional SELEX screening is labor-intensive and usually has a low success rate. How do we solve this problem?

    Some scholars have proposed and implemented a new strategy, to study and develop high-affinity aptamers that can efficiently bind to small molecules. The core of this strategy is the use of existing DNA aptamers with thermal stability to give them new functions and targets. First, we collected the DNA aptamer library with excellent thermal stability and then predicted these aptamers using biological techniques. Through this prediction process, we could successfully select alternative aptamers with high affinity. To further test the above predictions, we used MST experiments to measure the strength of the aptamers and small molecules when binding, while we also simulated the interaction mechanism between them. The results of the simulations can also help us to determine whether that base pair plays a key role. In addition, the scientists have explored some non-SELEX screening methods, such as non-equilibrium capillary electrophoresis (NECEEM) of equilibrium mixtures, and non-SELEX capillary electrophoresis technology, which can efficiently express and select nucleic acid aptamers without multiple rounds of screening.Pro-SELEX technology, developed by Northwestern University after years of research, can realize the quantitative screening of aptamers with high binding affinity through microfluidic chips. This method can improve the accuracy and success rate of aptamer screening.TEK Biotech is committed to providing customers with a short screening cycle, and high successful efficiency of small molecule nucleic acid aptamer screening technology services, to help each customer's scientific research.

Consult Now Small Molecule Nucleic Acid Aptamer Screening Service

*
*
*
*
*
*
*
• For a detailed understanding of customer information protection, please visit Privacy Policy
• If you have any questions about our technical services, you can send an email to info@tekbiotech.com Or make a phone call 400-168-8285 Detailed Consultation。

To experience the reliable service of Tekbiotech please subscribe: